Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV003407587 | SCV004113714 | uncertain significance | INF2-related disorder | 2023-09-19 | criteria provided, single submitter | clinical testing | The INF2 c.149A>C variant is predicted to result in the amino acid substitution p.Tyr50Ser. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. However, an alternative missense change at the same amino acid position (i.e. p.Tyr50Asp) segregated with disease in five affected family members with adult-onset nephrotic syndrome (Sen et al. 2017. PubMed ID: 28780565). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Blueprint Genetics | RCV000157249 | SCV000206979 | uncertain significance | Proteinuria | 2014-11-28 | no assertion criteria provided | clinical testing |